Allogene Therapeutics Inc (ALLO) stock saw a modest uptick, ending the day at $2.35 which represents a slight increase of $0.19 or 8.80% from the prior close of $2.16. The stock opened at $2.15 and ...
Stocktwits on MSN56m
Context Therapeutics Stock Jumps Pre-Market On Analyst's Near 4x Upside View: Retail Pins High Hopes TooShares of Context Therapeutics Inc. rose over 7% in Wednesday's pre-market trading after JMP Securities initiated coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback